|
|
||||||||
Journal of Lipid Research, Vol 37, 1569-1578, Copyright © 1996 by Lipid Research, Inc.
M Tilly-Kiesi, P Knudsen, L Groop and MR Taskinen
We studied the subclasses of plasma lipoproteins in normolipidemic,
glucose-tolerant male relatives of noninsulin dependent diabetic patients
(NIDDM), who represented either the lowest (n = 14) or the highest (n = 18)
quintiles of fasting plasma insulin. The higher plasma triglyceride level
in the high insulin group (1.61 mmol/l vs. 0.87 mmol/l, P < 0.001) was
due to multiple differences in triglyceride-rich lipoproteins. The
concentrations of larger VLDL1, smaller VLDL2 particles, and IDL particles
were 3.8-fold, 2.5-fold, and 1.5-fold higher, respectively, in the high
insulin group than in the low insulin group (P < 0.01 or less). In
addition, hyperinsulinemic subjects had VLDL1, VLDL2, and IDL particles
enriched in lipids and poor in protein. The lower plasma HDL cholesterol
level in the high insulin group (1.20 mmol/l vs. 1.44 mmol/l, P < 0.01)
compared to the low insulin group was a consequence of a 27% reduction of
HDL2a concentration (P < 0.05) and a significantly reduced percentage of
cholesterol in HDL3a, HDL3b, and HDL3c subclasses. On the other hand, the
percentages of triglycerides in HDL2b, HDL2a, HDL3a, and HDL3b subclasses
were 76%, 79%, 61%, and 50% higher, respectively, in the high insulin group
than in the low insulin group (P < 0.01 or less). In the combined group,
the concentration of VLDL1 and VLDL2 correlated positively with the
concentrations of LDL2 and LDL3 and negatively with HDL2b and HDL2a
subclasses (P < 0.05 or less). In conclusion, normolipidemic, glucose-
tolerant but hyperinsulinemic relatives of NIDDM patients have
qualitatively similar lipoprotein abnormalities as NIDDM patients. These
abnormalities are not observed in insulin-sensitive relatives, suggesting
that they develop in concert with insulin resistance.
ARTICLES
Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group
Department of Medicine, University of Helsinki, Finland.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Ouguerram, T. Magot, Y. Zair, J. S. Marchini, B. Charbonnel, H. Laouenan, and M. Krempf Effect of Atorvastatin on Apolipoprotein B100 Containing Lipoprotein Metabolism in Type-2 Diabetes J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 332 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Garvey, S. Kwon, D. Zheng, S. Shaughnessy, P. Wallace, A. Hutto, K. Pugh, A. J. Jenkins, R. L. Klein, and Y. Liao Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance Diabetes, February 1, 2003; 52(2): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |